How to cite item

THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation

   
@article{APS11105,
	author = {Heng-hui Xu and Sheng-xin Hao and He-yang Sun and Xin-xin Dong and Yuan Lin and Han Lou and Li-min Zhao and Ping-ping Tang and Zi-jia Dou and Jing-jing Han and Meng-han Du and Zhou-xiu Chen and Philipp Kopylov and Dmitry Shchekochikhin and Xin Liu and Yong Zhang},
	title = {THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation},
	journal = {Acta Pharmacologica Sinica},
	volume = {45},
	number = {10},
	year = {2024},
	keywords = {},
	abstract = {Diabetic cardiomyopathy (DCM) is a complication of diabetes mellitus characterized by heart failure and cardiac remodeling. Previous studies show that tetrahydroberberrubine (THBru) retrogrades cardiac aging by promoting PHB2-mediated mitochondrial autophagy and prevents peritoneal adhesion by suppressing inflammation. In this study we investigated whether THBru exerted protective effect against DCM in db/db mice and potential mechanisms. Eight-week-old male db/db mice were administered THBru (25, 50 mg·kg−1·d−1, i.g.) for 12 weeks. Cardiac function was assessed using echocardiography. We showed that THBru administration significantly improved both cardiac systolic and diastolic function, as well as attenuated cardiac remodeling in db/db mice. In primary neonatal mouse cardiomyocytes (NMCMs), THBru (20, 40 μM) dose-dependently ameliorated high glucose (HG)-induced cell damage, hypertrophy, inflammatory cytokines release, and reactive oxygen species (ROS) production. Using Autodock, surface plasmon resonance (SPR) and DARTS analyses, we revealed that THBru bound to the domain of the receptor for advanced glycosylation end products (RAGE), subsequently leading to inactivation of the PI3K/AKT/NF-κB pathway. Importantly, overexpression of RAGE in NMCMs reversed HG-induced inactivation of the PI3K/AKT/NF-κB pathway and subsequently counteracted the beneficial effects mediated by THBru. We conclude that THBru acts as an inhibitor of RAGE, leading to inactivation of the PI3K/AKT/NF-κB pathway. This action effectively alleviates the inflammatory responses and oxidative stress in cardiomyocytes, ultimately leading to ameliorated DCM.},
	issn = {1745-7254},	url = {http://www.chinaphar.com/article/view/11105}
}